相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis
Xinrong Ma et al.
ONCOIMMUNOLOGY (2013)
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2
Xinrong Ma et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
Dawn M. Holt et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E2 Signaling
Hua-Jung Li et al.
CANCER DISCOVERY (2012)
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers
Desheng Weng et al.
BREAST CANCER RESEARCH (2012)
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer
Jocelyn Reader et al.
CANCER AND METASTASIS REVIEWS (2011)
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
J. E. Rundhaug et al.
CANCER AND METASTASIS REVIEWS (2011)
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
Dawn Holt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Prostaglandin E2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway
Juanjuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell Line
Balraj Singh et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Functional Heterogeneity of Breast Fibroblasts Is Defined by a Prostaglandin Secretory Phenotype that Promotes Expansion of Cancer-Stem Like Cells
Jenny A. Rudnick et al.
PLOS ONE (2011)
Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
Naoki Terada et al.
CANCER RESEARCH (2010)
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Karla Kerlikowske et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome
Jae Il Kim et al.
MOLECULAR CANCER RESEARCH (2010)
Prostaglandin E Receptor EP1 Suppresses Breast Cancer Metastasis and Is Linked to Survival Differences and Cancer Disparities
Xinrong Ma et al.
MOLECULAR CANCER RESEARCH (2010)
Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
Namita Kundu et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Prostaglandin E2 Stimulates Human Lung Carcinoma Cell Growth through Induction of Integrin-Linked Kinase: The Involvement of EP4 and Sp1
Ying Zheng et al.
CANCER RESEARCH (2009)
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling
Katia Boniface et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Prostaglandin E-2-EP4 signaling promotes immune inflammation through T(H)1 cell differentiation and T(H)17 cell expansion
Chengcan Yao et al.
NATURE MEDICINE (2009)
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist
Akio Murase et al.
LIFE SCIENCES (2008)
EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells -: Evidence of a BRCA1 and p300 exchange
Kotha Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
Paraic A. Kenny et al.
MOLECULAR ONCOLOGY (2007)
Targeting prostaglandin E EP receptors to inhibit metastasis
Amy M. Fulton et al.
CANCER RESEARCH (2006)
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
Li Yang et al.
CANCER RESEARCH (2006)
Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis
XR Ma et al.
CANCER RESEARCH (2006)
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence
SD Chell et al.
CANCER RESEARCH (2006)
Role of β-arrestin 1 in the metastatic progression of colorectal cancer
FG Buchanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+ T regulatory cell activities in lung cancer
S Sharma et al.
CANCER RESEARCH (2005)
Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells
AV Timoshenko et al.
EXPERIMENTAL CELL RESEARCH (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
